2022-08-15
Innovaderm extends a warm welcome to Dr. Jankicevic, a key opinion leader in the field of dermatology drug/device development and medical affairs who will oversee our global clinical development and medical strategy. To learn more: https://lnkd.in/gSRi3Ts9
Innovaderm recently organized a unique fundraising challenge in the interest of supporting institutions in Poland who are helping displaced Ukranians to their country. Our goal was to cover 6,500 km (the distance between Montreal and Warsaw!) via walking, running, biking, or even kayaking! For every km traveled between June 3 and July 7, Innovaderm committed […]
[MONTREAL, QUEBEC – July 21, 2022] Innovaderm’s involvement in all phases of the clinical development of tapinarof culminated with a tremendous achievement: the recent approval of Dermavant Sciences’ VTAMA® (tapinarof) cream by the FDA for the treatment of plaque psoriasis in adults. Discovered in Canada, tapinarof is approved in the United States for the management […]
